Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05688995
Other study ID # ju
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 30, 2021
Est. completion date January 1, 2023

Study information

Verified date January 2023
Source University of Jordan
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aimed to explore the effect of different COVID-19 vaccines on menstrual cycle


Description:

This is a descriptive cross-sectional study that took place between September 2021 and December 2021. The study aimed to explore the effect of different COVID-19 vaccines on menstrual cycle. It used an anonymous questionnaire distributed via social media platforms; Facebook, Twitter, and WhatsApp across different cities of Jordan. A total of 732 responses were received with a 59% response rate. The questionnaire was distributed over four months directed at women who have received at least one dose of the COVID-19 vaccine and who live in Jordan. It took 10 minutes to complete all the questions. Data collection did not involve direct contact with participants to prevent the spread of COVID-19.


Recruitment information / eligibility

Status Completed
Enrollment 617
Est. completion date January 1, 2023
Est. primary completion date December 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - 18 years and older - less than 40 years - healthy women - received covid-19 vaccine Exclusion Criteria: - women who did not receive the vaccine - those living outside Jordan (those cannot fill the form) and during analysis.

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Naser Al-Husban
COVID-19 vaccines

Locations

Country Name City State
Jordan Jordan University Hospital Amman

Sponsors (1)

Lead Sponsor Collaborator
University of Jordan

Country where clinical trial is conducted

Jordan, 

Outcome

Type Measure Description Time frame Safety issue
Primary significant changes in the menstrual cycle after vaccination changes that involve bleeding amount or pain 6 months
See also
  Status Clinical Trial Phase
Completed NCT01927471 - Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Completed NCT00392873 - Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity N/A
Completed NCT05083065 - Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
Recruiting NCT04940013 - Missed Period Pill Study Phase 4
Completed NCT03547453 - Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
Completed NCT04985591 - The Effect of Liposuction on Menses: a Retrospective Study Early Phase 1
Completed NCT06339476 - Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers N/A
Completed NCT04006171 - Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women N/A
Completed NCT01555190 - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone N/A
Active, not recruiting NCT05230316 - Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
Completed NCT05410314 - Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma
Withdrawn NCT05518006 - An Investigation of Premama Balance and Its Effects on Hormonal Imbalances N/A
Not yet recruiting NCT05224726 - Platelet Rich Plasma for Uterine Scar N/A
Completed NCT04413058 - Menstrual Cycle Characteristics of Healthcare Professionals
Recruiting NCT05197491 - Women's Menstruation During the Covid-19 Pandemic